Ana I. Gil

Efficacy and safety of the CVnCoV SARS-CoV-2 mRNA vaccine candidate in ten countries in Europe and Latin America (HERALD): a randomised, observer-blinded, placebo-controlled, phase 2b/3 trial

Peter G. Kremsner, Rodolfo Andrés Ahuad Guerrero, Eunate Arana‐Arri et al. · The Lancet Infectious Diseases · 2021 · 175 citations · Full text

Veterinary Medicine, Infectious Diseases, Molecular Virology +16

New insights on the emergence of cholera in Latin America during 1991: the Peruvian experience.

Carlos Seas, J. Jaime Miranda, Ana I. Gil et al. · American Journal of Tropical Medicine and Hygiene · 2000 · 84 citations · Full text

Veterinary Medicine, Infectious Diseases, Clinical Epidemiology +16

Safety and immunogenicity of mRNA-LNP COVID-19 vaccine CVnCoV in Latin American adults: A phase 2 randomized study

Xavier Sáez‐Llorens, Claudio F. Lanata, Elaine Aranguren et al. · Vaccine X · 2022 · 20 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

The value of the continuous genotyping of multi-drug resistant tuberculosis over 20 years in Spain

María José Iglesias, Daniel Ibarz, Alberto Cebollada et al. · Scientific Reports · 2020 · 12 citations · Full text

Public Health, Infectious Diseases, Preventive Medicine +17